Royal Bank Of Canada Harmony Biosciences Holdings, Inc. Transaction History
Royal Bank Of Canada
- $471 Billion
- Q3 2024
A detailed history of Royal Bank Of Canada transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 4,684 shares of HRMY stock, worth $181,083. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,684
Previous 12,068
61.19%
Holding current value
$181,083
Previous $364,000
48.63%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding HRMY
# of Institutions
246Shares Held
45.5MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$434 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$226 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$134 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$101 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$88.1 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.29B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...